User profiles for J.M. Escallon
 | Jaime EscallonAssociate Professor of Surgery U. of Toronto Verified email at uhn.ca Cited by 1947 |
Ultrasound-guided multilevel paravertebral blocks and total intravenous anesthesia improve the quality of recovery after ambulatory breast tumor resection
…, PJ Morgan, T Cil, A McNaught, JM Escallon… - …, 2014 - pubs.asahq.org
Background: Regional anesthesia improves postoperative analgesia and enhances quality
of recovery (QoR) after ambulatory surgery. This randomized, double-blinded, parallel-group…
of recovery (QoR) after ambulatory surgery. This randomized, double-blinded, parallel-group…
[HTML][HTML] Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study
…, M Ennis, DR McCready, WL Leong, JM Escallon… - Breast cancer …, 2015 - Springer
Introduction The antidiabetic drug metformin exhibits potential anticancer properties that are
believed to involve both direct (insulin-independent) and indirect (insulin-dependent) actions…
believed to involve both direct (insulin-independent) and indirect (insulin-dependent) actions…
TARGIT-R (Retrospective): North American experience with intraoperative radiation using low-kilovoltage X-rays for breast cancer
…, J Ruffer, L Bravo, A Police, JM Escallon… - Annals of surgical …, 2016 - Springer
Background Single-dose intraoperative radiotherapy (IORT) is an emerging treatment for
women with early stage breast cancer. The objective of this study was to define the frequency …
women with early stage breast cancer. The objective of this study was to define the frequency …
Comparing the DN4 tool with the IASP grading system for chronic neuropathic pain screening after breast tumor resection with and without paravertebral blocks: a …
Investigating protective strategies against chronic neuropathic pain (CNP) after breast
cancer surgery entails using valid screening tools. The DN4 (Douleur Neuropathique en 4 …
cancer surgery entails using valid screening tools. The DN4 (Douleur Neuropathique en 4 …
[PDF][PDF] Total nutritional therapy: a nutrition education program for physicians
…, M Santillana Cantella, P Savino Lloreda, JM Escallón - 2004 - researchgate.net
Objective: Almost half of all hospitalized patients are malnourished with low physician
awareness or implementation of nutrition support1. To address this problem, a 2-day immersion …
awareness or implementation of nutrition support1. To address this problem, a 2-day immersion …
Abstract PD03-06: Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer
…, SJ Done, S Hallak, N Hood, W Leong, JM Escallon… - Cancer Research, 2010 - AACR
Background: Numerous epidemiological and pre-clinical studies have associated potential
antineoplastic activity with the antidiabetic drug metformin in various tumor types including …
antineoplastic activity with the antidiabetic drug metformin in various tumor types including …
Sentinel nodes in breast cancer: relevance of axillary level II nodes and optimal number of nodes that need to be removed
JF Boileau, A Easson, JM Escallon, WL Leong… - Annals of Surgical …, 2008 - Springer
Background In some patients, the radiocolloid used to perform sentinel lymph node biopsy (SLNB)
for breast cancer appears in a number of lymph nodes and in different levels of the …
for breast cancer appears in a number of lymph nodes and in different levels of the …
[BOOK][B] Surgical oncology manual
… Jaime Escallon … Wright• Jaime Escallon … Jaime Escallon, MD, FRCSC, FACS
Department of Surgery University of Toronto Toronto, ON, Canada …
Department of Surgery University of Toronto Toronto, ON, Canada …
Prognostic significance of a positive axillary lymph node fine‐needle aspirate in patients with invasive breast carcinoma
BACKGROUND Image‐guided axillary lymph node fine‐needle aspirates (FNAs) correlate
well with pathologic lymph node staging in cases of invasive breast carcinoma. The objective …
well with pathologic lymph node staging in cases of invasive breast carcinoma. The objective …
Abstract PD03-05: Analysis of tumour cell signaling in response to neoadjuvant metformin in women with early stage breast cancer.
…, N Hood, DR McCready, W Leong, JM Escallon… - Cancer Research, 2012 - AACR
Background: The anti-diabetic drug metformin, commonly used to treat type 2 diabetes due
to its ability to reduce circulating glucose and insulin, has emerged as a potential anti-cancer …
to its ability to reduce circulating glucose and insulin, has emerged as a potential anti-cancer …
